Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

Company News Summary

Fisher & Paykel Healthcare Announces Settlement of Global Patent Infringement Litigation

21 Feb 2019  |  07:35:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: RMD & FPH Announce Settlement of Global Patent Litigation

Fisher & Paykel Healthcare announced an agreement with ResMed to settle all outstanding patent infringement disputes between the companies in all venues around the world. The settlement involves no payment or admission of liability by either side. Under the agreement, all ongoing infringement proceedings against named products will be dismissed, and each party will bear its own attorney fees and costs incurred in the global proceedings. As a result of the settlement, there will be no further infringement proceedings against ResMed products, including AirSense flow generators, AirFit P10, Swift LT and Swift FX masks, and ClimateLine heated tubes; or against the Company products including Simplus, Eson and Eson 2.

Please click here for full details

See more ASX300 News Announcements